FDA Questioned Safety of Injectafer Long Before Approval
The FDA approved Injectafer (ferric carboxymaltose) in July 2013 for the treatment of iron deficiency anemia in adult patients. The product is injected directly into…
FDA & Prescription Drugs
Iron Deficiency Anemia Patients Must Ask: What Form of Iron Are You Using?
If you’re about to get an iron injection to treat your iron deficiency anemia, there’s one question you should be sure to ask your doctor:…
Injectable Iron “Injectafer” Linked to Increased Severe Hypophosphatemia
Infectafer is one of two major forms of an injectable iron complex used to treat iron deficiency anemia (IDA) in adult patients who cannot take…
Zostavax Lawsuits May Soon be Consolidated in One Court
Federal Zostavax lawsuits may soon be consolidated into one court for pre-trial proceedings. The U.S. Judicial Panel on Multidistrict Litigation (JPML) will hear arguments both…
Texas Woman Seeks to Hold Manufacturers Liable for Onglyza Heart Failure
A Texas woman blames Onglyza (saxagliptin) for serious injuries she suffered after taking the medication to treat her type 2 diabetes. She recently filed a…
Packaging Errors in Taytulla & Mibelas 24 FE Leave Women at Risk of Unintended Pregnancy
Women taking birth control pills should always check new packages carefully, as there have been instances of birth control pills being packaged in the wrong…
Litigation Growing in Byetta, Januvia, and Victoza Pancreatic Cancer MDL
In December 2017, a federal appeals court reinstated nearly 700 type 2 diabetes medication lawsuits that had previously been dismissed, allowing the cases to move…
EMA Review Confirms that Zinbryta Risks Outweigh the Benefits
The European Medicines Agency (EMA) recently warned that the risks associated with multiple-sclerosis (MS) medication Zinbryta (daclizumab) outweighed its benefits. This, following the worldwide recall…
Juluca and Other HIV Meds May Increase Risk of Neural Tube Birth Defects
On May 18, 2018, the FDA warned patients and doctors that certain medications used to treat the human immunodeficiency virus (HIV) may be linked to…
Spanish Review Report Questions Development of MS Drug Zinbryta
In March 2018, manufacturers of the multiple sclerosis (MS) drug Zinbryta (daclizumab) initiated a worldwide withdrawal of the drug because of reports of brain inflammation…